Literature DB >> 7680988

Antiarrhythmic prophylaxis after acute myocardial infarction. Is lidocaine still useful?

S Nattel1, A Arenal.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 7680988     DOI： 10.2165/00003495-199345010-00002

Source DB:  PubMed          Journal:  Drugs        ISSN： 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  27 in total

1.  Clinical use and toxicity of intravenous lidocaine. A report from the Boston Collaborative Drug Surveillance Program.

Authors:  H J Pfeifer; D J Greenblatt; J Koch-Weser
Journal:  Am Heart J       Date:  1976-08       Impact factor: 4.749

Review 2.  Electrophysiological mechanisms of ventricular arrhythmias resulting from myocardial ischemia and infarction.

Authors:  M J Janse; A L Wit
Journal:  Physiol Rev       Date:  1989-10       Impact factor: 37.312

Review 3.  Lidocaine prophylaxis against ventricular fibrillation in acute myocardial infarction.

Authors:  H S Ribner; E S Isaacs; W H Frishman
Journal:  Prog Cardiovasc Dis       Date:  1979 Jan-Feb       Impact factor: 8.194

4.  Acute phase of myocardial infarction.

Authors:  A A Adgey; J D Allen; J S Geddes; R G James; S W Webb; S A Zaidi; J F Pantridge
Journal:  Lancet       Date:  1971-09-04       Impact factor: 79.321

5.  Relations between enzymatically estimated myocardial infarct size and early ventricular dysrhythmia.

Authors:  J R Cox; R Roberts; H D Ambos; G C Oliver; B E Sobel
Journal:  Circulation       Date:  1976-03       Impact factor: 29.690

6.  Age-dependent lidocaine disposition in patients with acute myocardial infarction.

Authors:  J Cusson; S Nattel; C Matthews; M Talajic; S Lawand
Journal:  Clin Pharmacol Ther       Date:  1985-04       Impact factor: 6.875

7.  Intramuscular lidocaine for prevention of lethal arrhythmias in the prehospitalization phase of acute myocardial infarction.

Authors:  R W Koster; A J Dunning
Journal:  N Engl J Med       Date:  1985-10-31       Impact factor: 91.245

8.  Improved observational method for studying therapeutic efficacy. Suggestive evidence that lidocaine prophylaxis prevents death in acute myocardial infarction.

Authors:  R I Horwitz; A R Feinstein
Journal:  JAMA       Date:  1981-11-27       Impact factor: 56.272

9.  Prophylactic versus selective lidocaine for early ventricular arrhythmias of myocardial infarction.

Authors:  D G Wyse; J Kellen; A W Rademaker
Journal:  J Am Coll Cardiol       Date:  1988-08       Impact factor: 24.094

10.  In-hospital prognosis of patients with acute myocardial infarction complicated by primary ventricular fibrillation.

Authors:  A Volpi; A Maggioni; M G Franzosi; S Pampallona; F Mauri; G Tognoni
Journal:  N Engl J Med       Date:  1987-07-30       Impact factor: 91.245
View more
  3 in total

1.  Pharmacological Therapy of Cardiac Arrhythmias.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1998-11       Impact factor: 2.300

Review 2.  Clinically significant pharmacokinetic interactions between dietary caffeine and medications.

Authors:  J A Carrillo; J Benitez
Journal:  Clin Pharmacokinet       Date:  2000-08       Impact factor: 6.447

Review 3.  Pharmacoeconomics of lipid-lowering agents for primary and secondary prevention of coronary artery disease.

Authors:  J W Hay; W M Yu; T Ashraf
Journal:  Pharmacoeconomics       Date:  1999-01       Impact factor: 4.558
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.